Menu Search
Equities

Microbix Biosystems Inc

MBXBF:QXE

Microbix Biosystems Inc

Actions
  • Price (USD)0.2535
  • Today's Change0.000 / 0.00%
  • Shares traded500.00
  • 1 Year change+18.06%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 20:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CADIncome statement in CADView more

Year on year Microbix Biosystems Inc's revenues fell -13.43% from 19.08m to 16.51m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a gain of 1.79m to a loss of 39.48k.
Gross margin57.21%
Net profit margin21.73%
Operating margin21.73%
Return on assets14.10%
Return on equity20.04%
Return on investment16.10%
More ▼

Cash flow in CADView more

In 2023, cash reserves at Microbix Biosystems Inc fell by 1.88m. Cash Flow from Financing totalled 229.21k or 1.39% of revenues. In addition the company used 1.09m for operations while cash used for investing totalled 1.02m.
Cash flow per share0.0479
Price/Cash flow per share7.13
Book value per share0.205
Tangible book value per share0.1732
More ▼

Balance sheet in CADView more

Microbix Biosystems Inc appears to have a strong balance sheet with enough cash in the capital structure to pay down 100% of the liabilities.
Current ratio6.62
Quick ratio4.89
Total debt/total equity0.2268
Total debt/total capital0.1849
More ▼

Growth rates in CAD

SmartText is unavailable
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		304.43
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.